Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Version
11/10/2015
Revision date
2015-11-10
Product name
Levetiracetam Injection USP
Product name
Levetiracetam Injection USP
Identification on the label/Trade name
Levetiracetam Injection USP | Manufacturer Distributed / Manufactured by Fresenius Kabi USA LLC
Manufacturer Name
Fresenius Kabi USA, LLC
Icons in SDS
Company Information
company name
Fresenius Kabi USA, LLC
GHS Information
Signal word
DANGER
Hazard Codes
Hazard statements (CLP)
H317, H336, H361, H362, H372
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
Signal word
DANGER. GHS Class Specific Target Organ Toxicity -STOT Repeated exposure RE. Category 1 (Oral, Nervous system). Reproductive toxicity. Category 2. Skin Sensitization. Category 1. Specific Target Organ Toxicity - STOT, Single Exposure SE. Category 3. Reproductive toxicity. Effects on or via lactation.
Hazard statements
Causes damage to organs through prolonged or repeated exposure. Suspected of damaging fertility or the unborn child. May cause an allergic skin reaction. May cause drowsiness or dizziness. May cause harm to breast-fed children.
Precautionary statements
Obtain special instructions before use. Do not handle until all safety precautions have been read and understood. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid breathing dust/fume/gas/mist/vapours/spray. Avoid contact during pregnancy and while nursing. Wash hands thoroughly after handling. Do not eat, drink or smoke when using this product. Use only outdoors or in a well-ventilated area. Contaminated work clothing should not be allowed out of the workplace. Wear protective gloves/protective clothing/eye protection/face protection. IF ON SKIN: Wash with plenty of water. IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. IF exposed or concerned: Get medical advice/attention. Call a POISON CENTER or doctor/physician if you feel unwell. Get medical advice/attention if you feel unwell. Specific treatment (see ... on this label). If skin irritation or rash occurs: Get medical advice/attention. Take off contaminated clothing and wash it before reuse. Store in a well-ventilated place. Keep container tightly closed. Store locked up. Dispose of contents/container in accordance with Local, State, Federal and Provincial regulations. Emergency Overview This product is intended for therapeutic use only when prescribed by a physician. Potential adverse reactions from prescribed doses and overdoses are described in the package insert.
Principle Routes of Exposure
Inhalation Ingestion Eye contact Skin Absorption. Injection.
Potential health effects
Eye: Skin Contact with eyes may cause irritation. May cause skin irritation. Inhalation May cause irritation of respiratory tract. Ingestion May cause irritation. Signs/Symptoms The substance is used for the treatment of epilepsy and is generally well tolerated after repeated oral intake up to 3000 mg/day. The most frequently reported adverse events are drowsiness, weakness, and dizziness
